3G mobile phones: 31 million European subscribers in 2005

Published By Datamonitor

Alzheimer's disease: an opportunity for expansion?

Alzheimer's disease is reaching epidemic proportions. However, less than half of those affected seek diagnosis, mistakenly believing that there are no effective treatments available. With the number of sufferers set to triple in the next 30-40 years, many drug companies are battling to grab a share of this lucrative market, but will they be able to develop drugs effective enough to capitalize?

Published By Datamonitor

AP Moller-Maersk: delivering a mixed bag

Shipping company AP Moller-Maersk has released its results for 2006. Although overall revenue increased, profitability collapsed due to its container business unit suffering from over-supply in the industry. While the company forecasted a positive picture for 2007, further diversification may be required.

Published By Datamonitor

Baugur: another acquisition

Baugur's latest acquisition, through its subsidiary M-Invest, follows the company's strategy of buying up smaller fashion brands with a distinctive style and international growth potential. Its retail interests are providing it with a wide network of interlinking businesses that produce mutual benefits and faster growth opportunities.

Published By Datamonitor

Car leasing: Danish market to increase by third by 2005

Published By Datamonitor

Cialis: standing ovation for new launch

The launch of Viagra, the world's first treatment for impotency and erectile dysfunction, was an instant success. Now, Lilly ICOS has officially launched Cialis, Viagra's first direct competition, and there is more on the way. In a growing market, Cialis' advantages over Viagra mean that it could reach blockbuster status.

Published By Datamonitor

Consignia: outsourcing and expansion

Published By Datamonitor

Curalogic: closer to entering the immunotherapy arena

Curalogic has initiated a phase III trial with its product for oral immunotherapy of ragweed allergy. While traditional disease-modifying immunotherapeutics are administered by subcutaneous injection, Curalogic is developing a more convenient orally administered drug. Despite this advantage, a licensing-deal with a large respiratory player will be essential to exploit the drug's full potential.

Published By Datamonitor

Danish forecourts: shopping is key as sites disappear

One of Denmark's leading players, DK Benzin, has testified to the dramatic transformation of the fuel retailing market by predicting hundreds of sites will shut by 2007. In the aftermath of fierce price wars, and the government's support of decommissioning sites, closures seem inevitable. However, fuel retailers will now have the opportunity to focus their efforts on developing forecourt shops.

Published By Datamonitor

Denmark broadband: VDSL market will be worth $22 million by 2006

Published By Datamonitor